workforce | pharmaphorum

Skip to main content

Tuesday 1 September 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

workforce

Sales & Marketing

Scissors snipping off half of workforce concept

The hidden risks of biotech layoffs: Why cost-cutting trigge...

Reducing your team without a strategic risk plan actually spikes corporate vulnerability more than it lowers burn rates.

R&D

Ringaskiddy, Ireland

Biopharma’s future in Ireland: Stability, regulation & talen...

As increasing global competition from incentives is felt globally, Ireland needs to become even more agile.

Sales & Marketing

job search in newspaper with magnifying glass

Marketing yourself isn’t selling out. It’s smart science.

The call lasted ten minutes. My manager was apologetic. HR was professional.

News

UK facing alarming loss of scientific talent overseas

UK facing alarming loss of scientific talent overseas

Two new reports suggest the UK is seeing an exodus of skilled STEM workers to other countries, placing the country's economic future at risk.

Digital

random metal blocks

Building an AI-ready workforce in life sciences

Sales & Marketing

Representation of female executive burnout with head as matchstick

Biopharma's costly blind spot: Exhausted minds, expensive mi...

Burnout isn't just a personal issue anymore; it’s a strategic imperative.

Load more results

Editor's Picks

Revolution's ASCO showstopper gets FDA greenlight

Anthropic AI tool conducts physical scientific experiments

UK MHRA authorises orforglipron private prescription

Roche’s Genentech strikes $2.3bn deal for Hanmi obesity drug HM17321

Sword Health buys Headspace in $200m to $300m deal

News

Enhertu OK ends 10-year EU gap in frontline breast cancer

Enhertu OK ends 10-year EU gap in frontline breast cancer

Enhertu plus Perjeta has become the first new frontline therapy approved for advanced HER2-positive breast cancer in the EU for over a decade.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company